Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform.
Nguyen JL, Mitratza M, Volkman HR, de Munter L, Tran TMP, Marques C, Mustapha M, Valluri S, Yang J, Antón A, Casas I, Conde-Sousa E, Drikite L, Grüner B, Icardi G, Ten Kate GL, Martin C, Mira-Iglesias A, Orrico-Sánchez A, Otero-Romero S, Rohde G, Jodar L, McLaughlin JM, Bollaerts K.
Nguyen JL, et al. Among authors: martin c.
EClinicalMedicine. 2024 Dec 9;79:102995. doi: 10.1016/j.eclinm.2024.102995. eCollection 2025 Jan.
EClinicalMedicine. 2024.
PMID: 39726669
Free PMC article.